Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1 Hepatitis C Virus”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01290731
What this trial is testing

TMC435 in Genotype 1, Hepatitis C-infected Patients Who Relapsed After Previous Interferon (IFN)-Based Therapy

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 49
Large-scale testing (Phase 3)Study completedNCT01979939
What this trial is testing

UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 416
Testing effectiveness (Phase 2)Study completedNCT00377182
What this trial is testing

Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 107
Testing effectiveness (Phase 2)Study completedNCT01441180
What this trial is testing

GS-7977 With Ribavirin for Hepatitis C (SPARE)

Who this might be right for
Hepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 60
Large-scale testing (Phase 3)Ended earlyNCT02791256
What this trial is testing

Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 23
Testing effectiveness (Phase 2)Study completedNCT02254707
What this trial is testing

Evaluation of the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW to Patients With Chronic Hepatitis C Genotype 1 Virus Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 96
Post-approval studies (Phase 4)Study completedNCT00629967
What this trial is testing

Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients

Who this might be right for
Chronic Hepatitis CGenotype
Kaohsiung Medical University Chung-Ho Memorial Hospital 200
Post-approval studies (Phase 4)WithdrawnNCT03143998
What this trial is testing

Efficacy and Safety of Elbasvir/Grazoprevir in Brazilian Participants With Chronic Hepatitis C Virus (HCV) Genotype 1 Infection With Advanced Fibrosis (F3 and F4)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)WithdrawnNCT01579019
What this trial is testing

RO5024048 in Combination With Ritonavir-Boosted Danoprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C Genotype 1 Who Have Failed Prior HCV Protease Inhibitor Treatment

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche
Large-scale testing (Phase 3)Study completedNCT02006745
What this trial is testing

Open Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT)

Who this might be right for
HIV
St Stephens Aids Trust 20
Large-scale testing (Phase 3)Study completedNCT02105467
What this trial is testing

Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060)

Who this might be right for
Chronic Hepatitis C Virus
Merck Sharp & Dohme LLC 421
Testing effectiveness (Phase 2)Study completedNCT00987337
What this trial is testing

Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects

Who this might be right for
HepatitisHepatitis C
Pfizer 288
Not applicableStudy completedNCT00926016
What this trial is testing

Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects

Who this might be right for
Chronic Hepatitis C
Brooke Army Medical Center 23
Large-scale testing (Phase 3)Study completedNCT02032875
What this trial is testing

Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 116
Testing effectiveness (Phase 2)Study completedNCT00148837
What this trial is testing

Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis

Who this might be right for
Hepatitis C, ChronicFibrosis
French National Agency for Research on AIDS and Viral Hepatitis 112
Large-scale testing (Phase 3)Study completedNCT03222583
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 546
Post-approval studies (Phase 4)WithdrawnNCT01415141
What this trial is testing

Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism

Who this might be right for
Hepatitis C
University of Vermont
Large-scale testing (Phase 3)Ended earlyNCT01718301
What this trial is testing

HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin

Who this might be right for
Hepatitis CHIV InfectionsCOINFECTION
Anna Cruceta 108
Testing effectiveness (Phase 2)Study completedNCT01016912
What this trial is testing

Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha-2b and Ribavirin) in Japanese Patients

Who this might be right for
Hepatitis C Infection
Bristol-Myers Squibb 51
Large-scale testing (Phase 3)Study completedNCT01358864
What this trial is testing

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 678
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation